Opendata, web and dolomites

LPPDS

A portable peritoneal dialysis system for home use that monitors for infection

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 LPPDS project word cloud

Explore the words cloud of the LPPDS project. It provides you a very rough idea of what is the project "LPPDS" about.

patent    requiring    exchange    epidemics    function    economic    truly    treatment    patient    consists    adherence    travelling    pd    errors    aging    caused    pump    doctors    last    filtering    travel    monitoring    renal    minutes    53    esrd    ckd    fluid    population    schedules    saving    obesity    carry    home    liberdi    patients    poorer    transplant    globally    kidney    difficult    waste    lppds    share    external    portable    prevalence    connectors    end    occurs    time    disease    plans    eskd    peristaltic    compliance    lightweight    times    inhibit    longer    decreasing    hypertension    dialysis    day    stage    revolutionises    west    hospitals    hours    hd    choosing    human    protocol    session    issue    device    kidneys    latter    correct    centres    public    disposable    ease    chronic    reduce    fifth    week    seeing    doctor    ux    either    calculate    market    health    smart    haemodialysis    flow    catheters    socio    automation    takes    rate    peritoneal    speeds    complexity    adding    offerings    holds    blood    sterile    pending    diabetes    recognised    core    decline    efficacy    designed    sufficiently   

Project "LPPDS" data sheet

The following table provides information about the project.

Coordinator
LIBERDI LTD 

Organization address
address: 17 T'CHELET STREET
city: MISGAV
postcode: 2017400
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Israel [IL]
 Project website http://www.liberdi.com
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs)
3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
 Code Call H2020-SMEInst-2018-2020-1
 Funding Scheme SME-1
 Starting year 2018
 Duration (year-month-day) from 2018-08-01   to  2018-11-30

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    LIBERDI LTD IL (MISGAV) coordinator 50˙000.00

Map

 Project objective

End Stage Kidney Disease (ESKD) or End Stage Renal Disease (ESRD), the fifth and last stage of Chronic Kidney Disease (CKD), is recognised as a major public health problem. It occurs where kidneys are no longer capable of sufficiently filtering waste products from the blood. With kidney function at less than 10 %, a kidney transplant or an external means of filtering is needed. The latter consists of either Haemodialysis (HD) or Peritoneal Dialysis (PD). Globally, we are seeing an increasing prevalence in ESRD. This is caused by an aging population in the west, socio-economic factors, increasing hypertension, and growing diabetes and obesity epidemics.

The technical complexity of market offerings can inhibit many patients from choosing PD. HD takes an average of 4 hours per treatment session and occurs 3 times a week while PD occurs 4 times a day with each exchange requiring 40 minutes on average. Most dialysis occurs in specific dialysis centres and hospitals, adding further time for travel. Non-compliance with treatment schedules are a particular issue with PD. This makes it difficult for doctors to calculate correct treatment plans as patients may not share this information with their doctor. Non-compliance can be as high as 53%, decreasing efficacy of the treatment leading to poorer health overall and speeds up rate of decline.

liberDi revolutionises traditional Peritoneal Dialysis with LPPDS, a smart, real-time, patient-monitoring, truly portable device. It’s lightweight, easy to set up and allows patients carry out their dialysis at home, at work or while travelling. LPPDS has UX at the very core of its design to ensure ease of use: patent pending smart automation, catheters and sterile connectors. The system consists of a patent-pending disposable that holds a smart peristaltic pump designed to improve adherence to protocol, and reduce human errors, while saving time via fluid flow rate and management.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "LPPDS" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "LPPDS" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.3.;H2020-EU.2.1.)

Colourganisms (2020)

Microbial production of custom-made, pure and sustainable anthocyanins

Read More  

BeatsDigTherapeutics (2019)

Project SCALE: Tailored Digital Therapeutics for Neurological and Brain Disorders

Read More  

RoboSynFarm (2019)

Robotic Synthesis Farm

Read More